Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

China flag China · Delayed Price · Currency is CNY
56.99
+1.29 (2.32%)
At close: Mar 6, 2026
71.92%
Market Cap 15.10B
Revenue (ttm) 1.47B
Net Income (ttm) 123.17M
Shares Out 264.98M
EPS (ttm) 0.47
PE Ratio 121.30
Forward PE 80.27
Dividend n/a
Ex-Dividend Date n/a
Volume 4,475,720
Average Volume 5,798,149
Open 55.44
Previous Close 55.70
Day's Range 55.00 - 57.14
52-Week Range 26.61 - 90.68
Beta -0.40
RSI 29.12
Earnings Date Mar 25, 2026

About SHE:300049

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules. The diagnostic equipment R&D, production and sales segment develops, produces, and sells the FibroScan series of liver fibrosis diagnostic instrument... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 867
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300049
Full Company Profile

Financial Performance

In 2024, SHE:300049's revenue was 1.35 billion, an increase of 16.93% compared to the previous year's 1.15 billion. Earnings were 113.29 million, an increase of 11.54%.

Financial Statements

News

There is no news available yet.